Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba
Background. Pityriasis alba (PA) is a frequent cause of consultation in tropical areas due to its chronic course, frequent relapses, and notorious hypopigmented lesions in pediatric dark skin populations. Currently, no treatment is widely accepted. Objective. To assess the efficacy of 0.0003% calcit...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Dermatology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2012/303275 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832545444171874304 |
---|---|
author | Berenice Moreno-Cruz Bertha Torres-Álvarez Diana Hernández-Blanco Juan Pablo Castanedo-Cazares |
author_facet | Berenice Moreno-Cruz Bertha Torres-Álvarez Diana Hernández-Blanco Juan Pablo Castanedo-Cazares |
author_sort | Berenice Moreno-Cruz |
collection | DOAJ |
description | Background. Pityriasis alba (PA) is a frequent cause of consultation in tropical areas due to its chronic course, frequent relapses, and notorious hypopigmented lesions in pediatric dark skin populations. Currently, no treatment is widely accepted. Objective. To assess the efficacy of 0.0003% calcitriol and 0.1% tacrolimus ointments compared with placebo in the treatment of endemic PA. Methods. Twenty-eight children aged 3–17 years with 56 symmetrical lesions and phototype IV-V, were randomly assigned to receive the treatments on target lesions on the face. Improvement was evaluated at baseline and 8 weeks later clinically and by digital quantification of the affected area, colorimetry, and transepidermal water loss (TEWL). Results. Tacrolimus and calcitriol ointments induced a mean improvement of 68%, compared to 44% of placebo. We found an elevated TEWL in PA lesions. In the treated plaques, the reduction of the affected area was associated with improvement of pigmentation and TEWL. Conclusions. Calcitriol and tacrolimus induced similar repigmentation in endemic PA lesions. Melanogenic, anti-inflammatory, and barrier defect restoration properties of these drugs may explain these findings. |
format | Article |
id | doaj-art-7233166823984028bd0d4f70a69ae2ab |
institution | Kabale University |
issn | 1687-6105 1687-6113 |
language | English |
publishDate | 2012-01-01 |
publisher | Wiley |
record_format | Article |
series | Dermatology Research and Practice |
spelling | doaj-art-7233166823984028bd0d4f70a69ae2ab2025-02-03T07:25:53ZengWileyDermatology Research and Practice1687-61051687-61132012-01-01201210.1155/2012/303275303275Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis AlbaBerenice Moreno-Cruz0Bertha Torres-Álvarez1Diana Hernández-Blanco2Juan Pablo Castanedo-Cazares3Dermatology Department, Hospital Central “Dr. Ignacio Morones Prieto”, Universidad Autónoma de San Luis Potosí, Avenida Carranza No. 2395, CP 78210, San Luis Potosi, MexicoDermatology Department, Hospital Central “Dr. Ignacio Morones Prieto”, Universidad Autónoma de San Luis Potosí, Avenida Carranza No. 2395, CP 78210, San Luis Potosi, MexicoDermatology Department, Hospital Central “Dr. Ignacio Morones Prieto”, Universidad Autónoma de San Luis Potosí, Avenida Carranza No. 2395, CP 78210, San Luis Potosi, MexicoDermatology Department, Hospital Central “Dr. Ignacio Morones Prieto”, Universidad Autónoma de San Luis Potosí, Avenida Carranza No. 2395, CP 78210, San Luis Potosi, MexicoBackground. Pityriasis alba (PA) is a frequent cause of consultation in tropical areas due to its chronic course, frequent relapses, and notorious hypopigmented lesions in pediatric dark skin populations. Currently, no treatment is widely accepted. Objective. To assess the efficacy of 0.0003% calcitriol and 0.1% tacrolimus ointments compared with placebo in the treatment of endemic PA. Methods. Twenty-eight children aged 3–17 years with 56 symmetrical lesions and phototype IV-V, were randomly assigned to receive the treatments on target lesions on the face. Improvement was evaluated at baseline and 8 weeks later clinically and by digital quantification of the affected area, colorimetry, and transepidermal water loss (TEWL). Results. Tacrolimus and calcitriol ointments induced a mean improvement of 68%, compared to 44% of placebo. We found an elevated TEWL in PA lesions. In the treated plaques, the reduction of the affected area was associated with improvement of pigmentation and TEWL. Conclusions. Calcitriol and tacrolimus induced similar repigmentation in endemic PA lesions. Melanogenic, anti-inflammatory, and barrier defect restoration properties of these drugs may explain these findings.http://dx.doi.org/10.1155/2012/303275 |
spellingShingle | Berenice Moreno-Cruz Bertha Torres-Álvarez Diana Hernández-Blanco Juan Pablo Castanedo-Cazares Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba Dermatology Research and Practice |
title | Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba |
title_full | Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba |
title_fullStr | Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba |
title_full_unstemmed | Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba |
title_short | Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba |
title_sort | double blind placebo controlled randomized study comparing 0 0003 calcitriol with 0 1 tacrolimus ointments for the treatment of endemic pityriasis alba |
url | http://dx.doi.org/10.1155/2012/303275 |
work_keys_str_mv | AT berenicemorenocruz doubleblindplacebocontrolledrandomizedstudycomparing00003calcitriolwith01tacrolimusointmentsforthetreatmentofendemicpityriasisalba AT berthatorresalvarez doubleblindplacebocontrolledrandomizedstudycomparing00003calcitriolwith01tacrolimusointmentsforthetreatmentofendemicpityriasisalba AT dianahernandezblanco doubleblindplacebocontrolledrandomizedstudycomparing00003calcitriolwith01tacrolimusointmentsforthetreatmentofendemicpityriasisalba AT juanpablocastanedocazares doubleblindplacebocontrolledrandomizedstudycomparing00003calcitriolwith01tacrolimusointmentsforthetreatmentofendemicpityriasisalba |